Kaletra sparks fight over price, distribution

03/26/2006 | Chicago Tribune (tiered subscription model)

A new version of Abbott Laboratories' AIDS drug Kaletra has set off a battle between the drug company and some advocates, with one group calling on Abbott to sell the drug at no profit in 117 needy countries and provide the recipe to generic drugmakers. Abbott says it has not obtained the regulatory approvals it needs to distribute the drug in African countries.

View Full Article in:

Chicago Tribune (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Fort Worth, TX